Evaluating the Effectiveness of Ursodeoxycholic Acid in Various Treatment Approaches for Canine Liver Dysfunction: A Comparative Study

Verma, Prashant and Arora, Niddhi and Kalita, Jyoti Chanda and Prasad, Amit and Mrigesh, Meena and Singh, Anand Kumar and Goswami, Rashmi and Nayal, Kalicharan (2024) Evaluating the Effectiveness of Ursodeoxycholic Acid in Various Treatment Approaches for Canine Liver Dysfunction: A Comparative Study. Journal of Advances in Biology & Biotechnology, 27 (6). pp. 824-830. ISSN 2394-1081

[thumbnail of Verma2762024JABB117358.pdf] Text
Verma2762024JABB117358.pdf - Published Version

Download (284kB)

Abstract

Evaluating the Effectiveness of Ursodeoxycholic Acid in Various Treatment Approaches for Canine Liver Dysfunction: A Comparative Study Prashant Verma Niddhi Arora Jyoti Chanda Kalita Amit Prasad Meena Mrigesh Anand Kumar Singh Rashmi Goswami Kalicharan Nayal

Liver dysfunction in dogs presents significant challenges to veterinary practice, with clinical symptoms ranging from modest to severe. For the development of optimised treatment strategies, this study was conducted at the College of Veterinary and Animal Sciences, G.B.P.U.A. & T. Pantnagar, U.S. Nagar (Uttarakhand) from September 2021 to April 2022 in dogs diagnosed with hepatic dysfunction. The study involved a therapeutic trial on dogs with liver impairment. 18 dogs diagnosed with hepatic dysfunction were divided into three groups, i.e., B, C, and D. Each group received different therapeutic protocols, and changes in hematobiochemical profiles were observed and compared before and after treatment. Dogs in Group B received urosdeoxycholic acid, Group C received ursodeoxycholic acid and silymarin while Group D received ursodeoxycholic acid and L-ornithine Ornithine L-aspartate. Haematological and biochemical parameters were evaluated at presentation and after 21 days of treatment. Urosdeoxycholic acid demonstrated efficacy in improving biochemical parameters, with additional benefits observed when combined with L-Ornithine, L-Aspartate, or Silymarin. Group D exhibited the most significant improvement, suggesting the effectiveness of combination therapy. These findings underline the importance of regular monitoring and appropriate therapeutics in managing hepatic dysfunction in dogs, with combination therapies offering enhanced recovery through hepatoprotective, antioxidant, and anti-inflammatory mechanisms.
05 30 2024 824 830 10.9734/jabb/2024/v27i6945 https://journaljabb.com/index.php/JABB/article/view/945 https://journaljabb.com/index.php/JABB/article/download/945/1882 https://journaljabb.com/index.php/JABB/article/download/945/1882 https://journaljabb.com/index.php/JABB/article/download/945/1883

Item Type: Article
Subjects: OA Open Library > Biological Science
Depositing User: Unnamed user with email support@oaopenlibrary.com
Date Deposited: 31 May 2024 06:20
Last Modified: 31 May 2024 06:20
URI: http://archive.sdpublishers.com/id/eprint/2697

Actions (login required)

View Item
View Item